Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

3.55
Delayed Data
As of 4:00pm ET
 -0.20 / -5.33%
Today’s Change
2.35
Today|||52-Week Range
6.45
-19.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.006.5M13.1M
 
 
 
Cost of Goods Sold0.000.004.9M7.4M
 
 
 
Depreciation And Amortization1.2M990.3K2.5M3.1M
 
 
 
 
 
 
Operating ExpensesGross Income-1.2M-990.3K-914.3K2.6M
 
 
 
 
 
General Expenses9.6M12.9M24.3M27.3M
 
 
 
 
 
Research And Development4.7M4.8M9.7M7.5M
 
 
 
 
 
Total Operating Expenses10.8M13.9M31.7M37.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.8M-13.9M-25.2M-24.7M
 
 
 
 
 
Extraordinary Credit86.6K278.4K1.4M0.00
 
 
 
 
Extraordinary Charge-1.4M--0.00-1.1M
 
 
 
Interest Expense On Debt301.7K0.00214.4K231.3K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.4M-13.6M-24.0M-25.9M
 
 
 
 
 
Income Taxes0.000.00-4.6M-339.4K
 
 
 
Preferred Dividend0.00---1.4M0.00
 
 
Net Income-12.4M-13.6M-19.4M-25.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.5M13.3M17.5M28.3M
 
 
 
 
 
Shares To Calculate EPS Diluted10.5M13.4M17.5M28.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.89-$1.03-$1.19-$0.90
 
 
 
 
 
EPS Diluted-$1.18-$1.03-$1.19-$0.90